ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib or Crizotinib and Vemurafenib in Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01531361
Recruitment Status : Active, not recruiting
First Posted : February 10, 2012
Last Update Posted : May 16, 2018
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : February 2020
  Estimated Study Completion Date : February 2021